What are the potential cardiovascular risks associated with hormone replacement therapy (HRT) in postmenopausal women?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18948249
Cited by: 0

Abstract

HRT may increase the risk of thromboembolic events and stroke in postmenopausal women, with oral formulations carrying a higher risk than transdermal options. Coronary heart disease risk is generally unaffected by HRT.

Fields of Study & Subjects

Menopause: Health Impacts and Treatments Hormonal and reproductive studies Estrogen and related hormone effects

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 March 2026
Language
EN